Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Provepharm Inc. recalls Dihydroergotamine Mesylate Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Discoloration
Products
  • Dihydroergotamine Mesylate Injection
Where it was sold

Nationwide within the United States

Nationwide

Units affected
2160 packs/5 ampules per pack = 10,800 ampules
About this recall
Dihydroergotamine Mesylate Injection, solution for injection, USP, 1 mg/mL Ampules, Rx Only, Distributed by: Provepharm Inc. 100 Springhouse Drive Suite 105, Collegeville, PA 19426, NDC 81284-411-05